India in Talks to Buy 50 Million Doses of Pfizer Vaccine
![](https://utworld.in/wp-content/uploads/2021/08/images-2021-08-11T175142.561.jpeg)
The Wall Street Journal reported on Wednesday that India is in talks to buy 50 million doses of Pfizer Inc’s COVID-19 vaccine from German partner BioNTech SE, citing people familiar with the subject.
The government has been depending primarily on the AstraZeneca vaccine made by the Serum Institute of India and a home-grown shot produced by Bharat Biotech, which launched one of the world’s largest vaccination efforts earlier this year.
Last week, the country approved Johnson &Johnson’s one-shot vaccine for emergency usage, joining the list of vaccines approved by AstraZeneca, Bharat Biotech, Russia’s Gamaleya Institute, and Moderna.
Pic Courtesy: google/ images are subject to copyright